The EPA’s percentage targets for EV adoption are not mandates but expectations for how automakers can meet its new regulations.

The move is hardly shocking, given the acrimonious nature of the battle. In recent weeks, Disney has stepped up its attacks on Trian and Peltz.

Amgen is testing a monthly injection that works differently and appears to help patients maintain their weight loss even after they stop taking it.

Some patients are willing to pay more for GLP-1 weight loss drugs like Wegovy than others — and it’s strongly correlated to their annual income.

Boeing CEO Dave Calhoun will step down at the end of 2024 in part of a broad management shakeup for the embattled aerospace giant.

Former Disney CEO Bob Chapek spoke to CNBC about ESPN and its future in his first public comments since his 2022 firing.

Medicare patients can soon get coverage for Novo Nordisk’s Wegovy as long as it is prescribed to reduce their risk of heart attacks and strokes.

Nike is in the midst of a broad restructuring to cut costs by about $2 billion over the next three years as consumer demand remains […]

Lululemon raised its holiday sales guidance in January after it saw sales trends come in “balanced across channels, categories, and geographies.”

In a legal battle over VIP bettors, Fanatics accuses DraftKings of creating a culture of retribution. DraftKings accuses Fanatics of corporate espionage.